Abstract
Hemangioblastomas (HB) are characterized by the presence of vacuolated tumor cells resembling the tumor cells seen in clear cell renal cell carcinomas (CRCC). The distinction between HB and metastatic CRCC in the brain is critical as they have different therapeutic and prognostic ramifications. The issue is further complicated by the possibility of both HB and metastatic CRCC in brains of patients with Von Hippel Lindau (VHL) disease. We studied the expression of a novel monoclonal antibody D2-40, which recognizes an oncofetal antigen (M2A) in HB and CRCC, by immunohistochemistry. The vacuolated tumor cells in all HB were stained positively with D2-40. Nineteen of 23 (83%) HB showed strong, membranous staining in the vacuolated tumor cells, and 4 of 23 (17%) showed weaker staining. No expression was seen in CRCC, either primary in the kidney (0/20), or metastatic CRCC in the brain (0/8). Three of the patients with HB also had VHL disease, and no difference was seen in D2-40 staining of HB in patients with or without VHL disease. Two of these three VHL disease patients had both primary CRCC and HB resected at our institution. In these two patients, strong D2-40 expression was seen in the HB, but no expression was seen in the CRCC, underlying the utility of this marker in distinguishing HB from CRCC in patients with VHL disease in addition to sporadic cases. In summary, the monoclonal antibody D2-40 is a useful marker to distinguish HB from CRCC.
Similar content being viewed by others
References
Andrew SM, Gradwell E (1986) Immunoperoxidase labeled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas. J Clin Pathol 39:917–919
Bailey D, Baumal R, Law J, Sheldon K, Kannampuzha P, Stratis M, Kahn H, Marks A (1986) Production of a monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA 83:5291–5295
Bailey D, Marks A, Stratis M, Baumal R (1991) Immunohistochemical staining of germ cell tumours and intratubular malignant germ cells of the testis using antibody to placental alkaline phosphate and a monoclonal anti-seminoma antibody. Mod Pathol 4:167–171
Bleistein M, Geiger K, Franz K, Stoldt P, Schlote W (2000) Transthyretin and transferrin in hemangioblastoma stromal cells. Pathol Res Pract 196:675–681
Bret P, Streichenberger N, Guyotat J (1999) Metastasis of renal carcinoma to a cerebellar hemangioblastoma in a patient with von Hippel Lindau disease: a case report. Br J Neurosurg 13:413–416
Brown DF, Dababo MA, Hladik CL, Eagan KP, White CL 3rd, Rushing EJ (1998) Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas. Mod Pathol 11:55–59
Burger PC, Scheithauer BW, Vogel FS (1991) Surgical pathology of the nervous system and its coverings, 3rd edn. Churchill Livingstone, New York, pp 373–386
Choi WW, Lewis MM, Lawson D, Yin-Goen Q, Birdsong GG, Cotsonis GA, Cohen C, Young AN (2004) Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 17:1–10
Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D (2001) Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48:55–63
Feldenzer JA, McKeever PE (1987) Selective localization of gamma-enolase in stromal cells of cerebellar hemangioblastomas. Acta Neuropathol (Berl) 72:281–285
Frank TS, Trojanowski JQ, Roberts SA, Brooks JJ (1989) A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor. Mod Pathol 2:638–651
Gouldesbrough DR, Bell JE, Gordon A (1988) Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal cell carcinoma. J Clin Pathol 41:861–865
Hoang MP, Amirkhan RH (2003) Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma. Am J Surg Pathol 27:1152–1156
Ismail SM, Jasani B, Cole G (1985) Histogenesis of hemangioblastomas: an immunocytochemical and ultrastructural study in a case of von Hippel-Lindau syndrome. J Clin Pathol 38:417–421
Jung SM, Kuo TT (2003) Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol Dec 2004 (Advanced online publication)
Kahn HJ, Marks A (2002) A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82:1255–1257
Kahn HJ, Bailey D, Marks A (2002) Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas. Mod Pathol 15:434–440
Lach B, Gregor A, Rippstein P, Omulecka A (1999) Angiogenic histogenesis of stromal cells in hemangioblastomas: ultrastructural and immunohistochemical study. Ultrastruct Pathol 23:299–310
Marks A, Sutherland DR, Bailey D, Iglesias J, Law J, Lei M, Yeger H, Banerjee D, Baumal R (1999) Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 80:569–578
Miller CR, Perry A (2004) Immunohistochemical differentiation of hemangioblastoma from metastatic clear cell renal carcinoma: an update. Adv Anat Pathol 11:325–326
Murakata LA, Ishak KG, Nzeako UC (2000) Clear cell carcinoma of the liver: a comparative immunohistochemical study with renal clear cell carcinoma. Mod Pathol 13:874–881
Omulecka A, Lach B, Alwasiak J, Gregor A (1995) Immunohistochemical and ultrastructural studies of stromal cells in hemangioblastomas. Folia Neuropathol 33:41–50
Scavelli C, Weber E, Agliano M, Cirulli T, Nico B, Vacca A, Ribatti D (2004) Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J Anat 204:433–449
Sim SJ, Ro JY, Ordonez NG, Park YW, Kee KH, Ayala AG (1999) Metastatic CRCC to the bladder: a clinicopathologic and immunohistochemical study. Mod Pathol 12:351–355
Zakharov A, Papaiconomou C, Djenic J, Midha R, Johnston M (2003) Lymphatic cerebrospinal fluid absorption pathways in neonatal sheep revealed by subarachnoid injection of Microfil. Neuropathol Appl Neurobiol 29:563–573
Acknowledgements
The authors are grateful to John C. Oberholtzer for many helpful discussions. We thank Ms. Theresa L. Pasha for her excellent technical expertise in performing the immunohistochemical stains.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roy, S., Chu, A., Trojanowski, J.Q. et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish hemangioblastomas from renal cell carcinomas. Acta Neuropathol 109, 497–502 (2005). https://doi.org/10.1007/s00401-005-0999-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-005-0999-3